NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 125 filers reported holding NATERA INC in Q1 2019. The put-call ratio across all filers is 21.50 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,975,000 | +32.8% | 289,764 | -10.1% | 0.31% | +14.3% |
Q4 2018 | $4,498,000 | -41.6% | 322,196 | +0.1% | 0.27% | -20.9% |
Q3 2018 | $7,705,000 | -8.9% | 321,843 | -28.4% | 0.34% | +4.2% |
Q2 2018 | $8,456,000 | +88.6% | 449,310 | -7.1% | 0.33% | +54.7% |
Q1 2018 | $4,484,000 | +2.7% | 483,663 | -0.4% | 0.21% | -1.4% |
Q4 2017 | $4,365,000 | -30.7% | 485,503 | -0.6% | 0.22% | -41.2% |
Q3 2017 | $6,296,000 | +20.5% | 488,453 | +1.6% | 0.37% | +5.4% |
Q2 2017 | $5,223,000 | +24.1% | 480,944 | +1.4% | 0.35% | +29.6% |
Q1 2017 | $4,208,000 | -29.5% | 474,453 | -7.0% | 0.27% | -39.6% |
Q4 2016 | $5,972,000 | -16.0% | 510,014 | -20.3% | 0.45% | -14.5% |
Q3 2016 | $7,110,000 | -18.7% | 639,961 | -11.7% | 0.52% | -29.8% |
Q2 2016 | $8,744,000 | +9.7% | 724,750 | -13.5% | 0.74% | +5.1% |
Q1 2016 | $7,973,000 | -8.6% | 837,477 | +3.7% | 0.71% | -13.7% |
Q4 2015 | $8,724,000 | +103.6% | 807,814 | +104.5% | 0.82% | +93.9% |
Q3 2015 | $4,285,000 | – | 394,956 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |